184 related articles for article (PubMed ID: 28255354)
1. Radionuclide I-131 Labeled Albumin-Paclitaxel Nanoparticles for Synergistic Combined Chemo-radioisotope Therapy of Cancer.
Tian L; Chen Q; Yi X; Wang G; Chen J; Ning P; Yang K; Liu Z
Theranostics; 2017; 7(3):614-623. PubMed ID: 28255354
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced co-assembly of albumin/catalase as smart nano-theranostics for deep intra-tumoral penetration, hypoxia relieve, and synergistic combination therapy.
Chen Q; Chen J; Liang C; Feng L; Dong Z; Song X; Song G; Liu Z
J Control Release; 2017 Oct; 263():79-89. PubMed ID: 27840167
[TBL] [Abstract][Full Text] [Related]
3. Biological evaluation of PEG modified nanosuspensions based on human serum albumin for tumor targeted delivery of paclitaxel.
Yin T; Cai H; Liu J; Cui B; Wang L; Yin L; Zhou J; Huo M
Eur J Pharm Sci; 2016 Feb; 83():79-87. PubMed ID: 26699227
[TBL] [Abstract][Full Text] [Related]
4. Self-promoted Albumin-Based Nanoparticles for Combination Therapy against Metastatic Breast Cancer via a Hyperthermia-Induced "Platelet Bridge".
Zhao W; Li T; Long Y; Guo R; Sheng Q; Lu Z; Li M; Li J; Zang S; Zhang Z; He Q
ACS Appl Mater Interfaces; 2021 Jun; 13(22):25701-25714. PubMed ID: 34041901
[TBL] [Abstract][Full Text] [Related]
5. Self-assembled PEGylated albumin nanoparticles (SPAN) as a platform for cancer chemotherapy and imaging.
Lee JE; Kim MG; Jang YL; Lee MS; Kim NW; Yin Y; Lee JH; Lim SY; Park JW; Kim J; Lee DS; Kim SH; Jeong JH
Drug Deliv; 2018 Nov; 25(1):1570-1578. PubMed ID: 30044159
[TBL] [Abstract][Full Text] [Related]
6. Damaging Tumor Vessels with an Ultrasound-Triggered NO Release Nanosystem to Enhance Drug Accumulation and T Cells Infiltration.
Xu Y; Liu J; Liu Z; Chen G; Li X; Ren H
Int J Nanomedicine; 2021; 16():2597-2613. PubMed ID: 33833514
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional theranostic contrast agent for photoacoustics- and ultrasound-based tumor diagnosis and ultrasound-stimulated local tumor therapy.
Moon H; Kang J; Sim C; Kim J; Lee H; Chang JH; Kim H
J Control Release; 2015 Nov; 218():63-71. PubMed ID: 26432554
[TBL] [Abstract][Full Text] [Related]
8. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer.
Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS
Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional Mesoporous Polydopamine With Hydrophobic Paclitaxel For Photoacoustic Imaging-Guided Chemo-Photothermal Synergistic Therapy.
Zhang L; Yang P; Guo R; Sun J; Xie R; Yang W
Int J Nanomedicine; 2019; 14():8647-8663. PubMed ID: 31806962
[TBL] [Abstract][Full Text] [Related]
10. Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer.
Kinoshita R; Ishima Y; Chuang VTG; Nakamura H; Fang J; Watanabe H; Shimizu T; Okuhira K; Ishida T; Maeda H; Otagiri M; Maruyama T
Biomaterials; 2017 Sep; 140():162-169. PubMed ID: 28651144
[TBL] [Abstract][Full Text] [Related]
11. Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug.
Battogtokh G; Kang JH; Ko YT
Eur J Pharm Biopharm; 2015 Oct; 96():96-105. PubMed ID: 26212785
[TBL] [Abstract][Full Text] [Related]
12. Hyperthermal paclitaxel-bound albumin nanoparticles co-loaded with indocyanine green and hyaluronidase for treating pancreatic cancers.
Kim SS; Kim HK; Kim H; Lee WT; Lee ES; Oh KT; Choi HG; Youn YS
Arch Pharm Res; 2021 Feb; 44(2):182-193. PubMed ID: 32803685
[TBL] [Abstract][Full Text] [Related]
13. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
14. A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy.
Shan L; Zhuo X; Zhang F; Dai Y; Zhu G; Yung BC; Fan W; Zhai K; Jacobson O; Kiesewetter DO; Ma Y; Gao G; Chen X
Theranostics; 2018; 8(7):2018-2030. PubMed ID: 29556370
[TBL] [Abstract][Full Text] [Related]
15. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
Xu C; Liu W; Hu Y; Li W; Di W
Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
17. Folate-receptor-targeted laser-activable poly(lactide-
Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of paclitaxel palmitate albumin nanoparticles with high loading efficacy: an in vitro and in vivo anti-tumor study in mouse models.
Chen H; Huang S; Wang H; Chen X; Zhang H; Xu Y; Fan W; Pan Y; Wen Q; Lin Z; Wang X; Gu Y; Ding B; Chen J; Wu X
Drug Deliv; 2021 Dec; 28(1):1067-1079. PubMed ID: 34109887
[TBL] [Abstract][Full Text] [Related]
19. Drug-Induced Self-Assembly of Modified Albumins as Nano-theranostics for Tumor-Targeted Combination Therapy.
Chen Q; Wang X; Wang C; Feng L; Li Y; Liu Z
ACS Nano; 2015 May; 9(5):5223-33. PubMed ID: 25950506
[TBL] [Abstract][Full Text] [Related]
20. Copper-Free 'Click' Chemistry-Based Synthesis and Characterization of Carbonic Anhydrase-IX Anchored Albumin-Paclitaxel Nanoparticles for Targeting Tumor Hypoxia.
Tatiparti K; Sau S; Gawde KA; Iyer AK
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
